Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Advanced Drainage Systems | WMS | Nov 19, 2024 | 129.07 | -3.12 |
Advanced Energy Industries | AEIS | Nov 19, 2024 | 111.56 | +1.57 |
Advanced Flower Capital | AFCG | Nov 19, 2024 | 9.63 | -0.21 |
Advanced Micro Devices | AMD | Nov 19, 2024 | 139.39 | +0.33 |
AdvanSix | ASIX | Nov 19, 2024 | 29.09 | -2.09 |
Advantage Solutions A | ADV | Nov 19, 2024 | 3.37 | +4.66 |
Advent | AVK | Nov 19, 2024 | 11.92 | +1.10 |
Advent Technologies A | ADN | Nov 19, 2024 | 6.23 | -0.32 |
Adverum Biotechnologies | ADVM | Nov 19, 2024 | 6.25 | -8.76 |
AdvisorShares Pure US Cannabis ETF | MSOS | Nov 19, 2024 | 4.68 | -4.68 |
Advisorshares Star Global Buy-Write ETF | VEGA | Nov 19, 2024 | 43.91 | +0.38 |
AECOM | ACM | Nov 19, 2024 | 108.83 | -0.27 |
Aegon N.V ADR | AEG | Nov 19, 2024 | 6.33 | -2.01 |
Aehr Test Systems | AEHR | Nov 19, 2024 | 11.16 | -0.89 |
Aemetis | AMTX | Nov 19, 2024 | 3.93 | +3.97 |
Aeon Biopharma | AEON | Nov 19, 2024 | 0.58 | -2.85 |
AerCap Holdings | AER | Nov 19, 2024 | 95.73 | +0.83 |
Aeries Technology | AERT | Nov 19, 2024 | 1.16 | -7.94 |
Aerospace & Defense Powershares | PPA | Nov 19, 2024 | 117.77 | +0.56 |
Aerovate Therapeutics | AVTE | Nov 19, 2024 | 2.67 | +5.53 |
AeroVironment | AVAV | Nov 19, 2024 | 194.89 | -1.11 |
AerSale | ASLE | Nov 19, 2024 | 6.11 | +1.66 |
AES | AES | Nov 19, 2024 | 13.75 | +0.07 |
Aetherium Acquisition A | GMFI | Nov 19, 2024 | 11.04 | 0.00 |
Aetherium Acquisition Unit | GMFIU | Nov 19, 2024 | 11.10 | 0.00 |
Aethlon Medical | AEMD | Nov 19, 2024 | 0.39 | +0.13 |
Aeva Technologies | AEVA | Nov 19, 2024 | 3.66 | -0.54 |
AEye A | LIDR | Nov 19, 2024 | 0.95 | +0.11 |
Affiliated Managers Group | AMG | Nov 19, 2024 | 183.11 | -1.10 |
Affimed N.V. | AFMD | Nov 19, 2024 | 3.00 | -5.06 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.